Hangzhou Xuanfeng Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hangzhou Xuanfeng Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SUPREFORM. The owner is based in Hangzhou, Zhejiang.

Room 1107, Building 2, Zhongbo Building

Xianlin Street, Yuhang District

Hangzhou, Zhejiang 311122 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Hangzhou Xuanfeng Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Hangzhou Xuanfeng Technology Co., Ltd. have?

Hangzhou Xuanfeng Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Hangzhou Xuanfeng Technology Co., Ltd. file in?

Hangzhou Xuanfeng Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Hangzhou Xuanfeng Technology Co., Ltd.'s most well-known trademarks?

Hangzhou Xuanfeng Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SUPREFORM. These are among 1 currently registered trademark in the portfolio.

What is Hangzhou Xuanfeng Technology Co., Ltd.'s trademark registration success rate?

Hangzhou Xuanfeng Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.